{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T04:32:04Z","timestamp":1777350724140,"version":"3.51.4"},"reference-count":28,"publisher":"Belitung Raya Foundation","issue":"2","license":[{"start":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T00:00:00Z","timestamp":1775347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"award":[""],"award-info":[{"award-number":[""]}]}],"content-domain":{"domain":["belitungraya.org"],"crossmark-restriction":true},"short-container-title":["Belitung Nurs J"],"abstract":"<jats:p>Background: Comorbidity treatment for people who use drugs with hepatitis C should be integrated with addiction treatment. Case management plays a crucial role in enhancing treatment motivation and improving treatment completion rates. Previous studies have focused on outcomes, disease, or treatment experiences. However, studies exploring the perspectives of people who use drugs living with hepatitis C on their interactions with case managers remain limited.\nObjective: To explore the perspectives of people who use drugs with hepatitis C receiving case management services on their interactions with case managers.\nMethods: This exploratory qualitative study was conducted in a psychiatric hospital in southern Taiwan that provides addiction treatment services for individuals with substance use disorders. Purposive sampling was used to recruit participants who had received case-managed HCV treatment and completed the full course of care. Semi-structured, in-depth interviews were conducted with nine participants in a private space within the hospital\u2019s outpatient clinic between September 2022 and December 2023 and analyzed using a qualitative content analysis.\nResults: Four themes were identified: (a) feeling empowered through respectful communication and shared decision-making, (b) transformation in health literacy and understanding of hepatitis C, (c) increased engagement in treatment facilitated by case management support, and (d) Diverse views of the importance of case managers\u2019 professional backgrounds. These perspectives reflected how case-managed HCV care shaped participants\u2019 experiences and engagement, underscoring the essential role of communication, education, and supportive relationships within addiction treatment settings.\nConclusion: The findings of this study highlight patients\u2019 perspectives on addiction case management and underscore the importance of trust-based communication, continuity of care, and tailored education in enhancing engagement in HCV care. These results provide practical implications for developing core competencies among addiction case managers in addressing the comorbidities of substance use and hepatitis C.<\/jats:p>","DOI":"10.33546\/bnj.4472","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T03:19:36Z","timestamp":1777346376000},"page":"242-249","update-policy":"https:\/\/doi.org\/10.33546\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the perspectives of people who use drugs living with hepatitis C on interactions with case managers: A qualitative study in Taiwan"],"prefix":"10.33546","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9631-1115","authenticated-orcid":false,"given":"Pei Chen","family":"Hsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5627-9969","authenticated-orcid":false,"given":"Hung-Chi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4642-4169","authenticated-orcid":false,"given":"Wan-Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6747-6909","authenticated-orcid":false,"given":"Jing-Jy","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"19163","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"149495","doi-asserted-by":"crossref","unstructured":"Anderson, R. M., & Funnell, M. M. (2010). Patient empowerment: myths and misconceptions. Patient Education and Counseling, 79(3), 277\u2013282. https:\/\/doi.org\/10.1016\/j.pec.2009.07.025","DOI":"10.1016\/j.pec.2009.07.025"},{"key":"149496","unstructured":"California Dental Association Foundation. (2021). Polaris Hepatitis C. http:\/\/cdafound.org\/polaris\/"},{"key":"149497","unstructured":"Centers for Disease Control and Prevention [CDC]. (2025). Hepatitis C Prevention and Control. Retrieved January 31, 2025 from https:\/\/www.cdc.gov\/hepatitis-c\/prevention\/"},{"key":"149498","doi-asserted-by":"crossref","unstructured":"Dai, C.-Y., Batsaikhan, B., & Huang, C.-F. (2024). \u2018One-stop-shop\u2019point-of-care hepatitis C RNA testing intervention in the prison\u2013some issues. Journal of Hepatology, 80(3), e106\u2013e107. https:\/\/doi.org\/10.1016\/j.jhep.2023.07.037","DOI":"10.1016\/j.jhep.2023.07.037"},{"key":"149499","doi-asserted-by":"crossref","unstructured":"Degenhardt, L., Peacock, A., Colledge, S., Leung, J., Grebely, J., Vickerman, P., Stone, J., Cunningham, E. B., Trickey, A., & Dumchev, K. (2017). Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: A multistage systematic review. The Lancet Global Health, 5(12), e1192\u2013e1207. https:\/\/doi.org\/10.1016\/S2214-109X(17)30375-3","DOI":"10.1016\/S2214-109X(17)30375-3"},{"key":"149500","doi-asserted-by":"crossref","unstructured":"Goodyear, T., Brown, H., Browne, A. J., Hoong, P., Ti, L., & Knight, R. (2021). \u201cI want to get better, but\u2026\u201d: Identifying the perceptions and experiences of people who inject drugs with respect to evolving hepatitis C virus treatments. International Journal for Equity in Health, 20(1), 81. https:\/\/doi.org\/10.1186\/s12939-021-01420-7","DOI":"10.1186\/s12939-021-01420-7"},{"key":"149501","doi-asserted-by":"crossref","unstructured":"Graneheim, U. H., & Lundman, B. (2004). Qualitative content analysis in nursing research: Concepts, procedures and measures to achieve trustworthiness. Nurse Education Today, 24(2), 105\u2013112. https:\/\/doi.org\/10.1016\/j.nedt.2003.10.001","DOI":"10.1016\/j.nedt.2003.10.001"},{"key":"149502","doi-asserted-by":"crossref","unstructured":"Groessl, E. J., Liu, L., Sklar, M., & Ho, S. B. (2017). HCV integrated care: A randomized trial to increase treatment initiation and SVR with direct acting antivirals. International Journal of Hepatology, 2017(1), 5834182. https:\/\/doi.org\/10.1155\/2017\/5834182","DOI":"10.1155\/2017\/5834182"},{"key":"149503","doi-asserted-by":"crossref","unstructured":"Hajarizadeh, B., Carson, J. M., Byrne, M., Grebely, J., Cunningham, E., Amin, J., Vickerman, P., Martin, N. K., Treloar, C., & Martinello, M. (2024). Incidence of hepatitis C virus infection in the prison setting: The SToP\u2010C study. Journal of Viral Hepatitis, 31(1), 21\u201334. https:\/\/doi.org\/10.1111\/jvh.13895","DOI":"10.1111\/jvh.13895"},{"key":"149504","doi-asserted-by":"crossref","unstructured":"Heffernan, A., Cooke, G. S., Nayagam, S., Thursz, M., & Hallett, T. B. (2019). Scaling up prevention and treatment towards the elimination of hepatitis C: A global mathematical model. The Lancet, 393(10178), 1319\u20131329. https:\/\/doi.org\/10.1016\/S0140-6736(18)32277-3","DOI":"10.1016\/S0140-6736(18)32277-3"},{"key":"149505","doi-asserted-by":"crossref","unstructured":"Hsieh, M.-H., Tsai, J.-J., Hsieh, M.-Y., Huang, C.-F., Yeh, M.-L., Yang, J.-F., Chang, K., Lin, W.-R., Lin, C.-Y., & Chen, T.-C. (2014). Hepatitis C virus infection among injection drug users with and without human immunodeficiency virus co-infection. PloS One, 9(4), e94791. https:\/\/doi.org\/10.1371\/journal.pone.0094791","DOI":"10.1371\/journal.pone.0094791"},{"key":"149506","doi-asserted-by":"crossref","unstructured":"Lee, K., & Nathan-Roberts, D. (2021). Using visual aids to supplement medical instructions, health education, and medical device instructions. Proceedings of the International Symposium on Human Factors and Ergonomics in Health Care, 10(1), 257\u2013262.","DOI":"10.1177\/2327857921101190"},{"key":"149507","doi-asserted-by":"crossref","unstructured":"Lincoln, Y. S., & Guba, E. G. (1985). Naturalistic inquiry. London: Sage.","DOI":"10.1016\/0147-1767(85)90062-8"},{"key":"149508","doi-asserted-by":"crossref","unstructured":"Madden, A., Hopwood, M., Neale, J., & Treloar, C. (2018). Beyond interferon side effects: what residual barriers exist to DAA hepatitis C treatment for people who inject drugs? PloS One, 13(11), e0207226. https:\/\/doi.org\/10.1371\/journal.pone.0207226","DOI":"10.1371\/journal.pone.0207226"},{"key":"149509","doi-asserted-by":"crossref","unstructured":"Mahoney, B. J., Morford, K. L., Biegacki, E. T., & Tetrault, J. M. (2024). Hepatitis C virus and integrated care for substance use disorders. Clinical Liver Disease, 23(1), e0241. https:\/\/doi.org\/10.1097\/CLD.0000000000000241","DOI":"10.1097\/CLD.0000000000000241"},{"key":"149510","unstructured":"Ministry of Health and Welfare [MOHW]. (2020). National hepatitis and liver cancer prevention and control plan (2015\u20132021). https:\/\/www.ey.gov.tw\/Page\/448DE008087A1971\/2bac1ee0-5c9b-459d-aadc-e90add01e0c2"},{"key":"149511","unstructured":"National Institute on Drug Abuse [NIDA]. (2014). Principles of drug addiction treatment: A research-based guide (3rd ed.). National Institute on Drug Abuse. https:\/\/nida.nih.gov\/sites\/default\/files\/podat_1.pdf"},{"key":"149512","doi-asserted-by":"crossref","unstructured":"Negro, F. (2020). Natural history of hepatic and extrahepatic hepatitis C virus diseases and impact of interferon-free HCV therapy. Cold Spring Harbor Perspectives in Medicine, 10(4), a036921. https:\/\/doi.org\/10.1101\/cshperspect.a036921","DOI":"10.1101\/cshperspect.a036921"},{"key":"149513","doi-asserted-by":"crossref","unstructured":"Pearce, M. E., Jongbloed, K., Demerais, L., MacDonald, H., Christian, W. M., Sharma, R., Pick, N., Yoshida, E. M., Spittal, P. M., & Klein, M. B. (2019). \u201cAnother thing to live for\u201d: supporting HCV treatment and cure among Indigenous people impacted by substance use in Canadian cities. International Journal of Drug Policy, 74, 52\u201361. https:\/\/doi.org\/10.1016\/j.drugpo.2019.08.003","DOI":"10.1016\/j.drugpo.2019.08.003"},{"key":"149514","unstructured":"SAMHSA. (2000). 2 Applying Case Management to Substance Abuse Treatment. In Comprehensive Case Management for Substance Abuse Treatment (Vol. 27). Substance Abuse and Mental Health Services Administration. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK571728\/"},{"key":"149515","doi-asserted-by":"crossref","unstructured":"Schladitz, K., Weitzel, E. C., L\u00f6bner, M., Soltmann, B., Jessen, F., Pfennig, A., Riedel-Heller, S. G., & G\u00fchne, U. (2023). Experiencing (shared) decision making: Results from a qualitative study of people with mental illness and their family members. Healthcare, 11(16), 2237. https:\/\/doi.org\/10.3390\/healthcare11162237","DOI":"10.3390\/healthcare11162237"},{"key":"149516","unstructured":"Substance Abuse and Mental Health Services Administration [SAMHSA]. (2021). Advisory: Comprehensive case management for substance use disorder treatment. https:\/\/library.samhsa.gov\/sites\/default\/files\/PEP20-02-02-013.pdf"},{"key":"149517","unstructured":"Taiwan Liver Research Foundation. (2024). Taiwan roadmap toward HCV elimination. https:\/\/www.taiwan-hcv-elimination.org\/index.php"},{"key":"149518","doi-asserted-by":"crossref","unstructured":"Varela, A. J., Gallamore, M. J., Hansen, N. R., & Martin, D. C. (2025). Patient empowerment: A critical evaluation and prescription for a foundational definition. Frontiers in Psychology, 15, 1473345. https:\/\/doi.org\/10.3389\/fpsyg.2024.1473345","DOI":"10.3389\/fpsyg.2024.1473345"},{"key":"149519","unstructured":"Wang, S.-C., Lin, P.-H., Chung, A.-N., Chung, Y.-J. E., & Chen, W. J. (2022). The most critical mile to eliminate hepatitis C: Current status and recommendations for the prevention and treatment of people who inject drugs. Taipei Journal of Public Health, 41(5), 479\u2013482. https:\/\/doi.org\/10.6288\/TJPH.202210_41(5).PF05"},{"key":"149520","unstructured":"World Health Organization [WHO]. (2025). Hepatitis C [Fact sheet]. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c"},{"key":"149521","doi-asserted-by":"crossref","unstructured":"Wu, G. H.-M., Yang, W.-W., Liu, C.-L., Cheng, K.-P., Chen, S.-C., Chen, C.-J., & Pwu, R.-F. (2021). Eliminating hepatitis C in Taiwan by 2025: strategies and progress [Eliminating hepatitis C in Taiwan by 2025: strategies and progress]. Taiwan Journal of Public Health, 40(1), 1\u20134. https:\/\/doi.org\/10.6288\/TJPH.202102_40(1).PF01","DOI":"10.1111\/liv.14412"},{"key":"149522","doi-asserted-by":"crossref","unstructured":"Yu, M.-L., Yeh, M.-L., Tsai, P.-C., Huang, C.-I., Huang, J.-F., Huang, C.-F., Hsieh, M.-H., Liang, P.-C., Lin, Y.-H., & Hsieh, M.-Y. (2015). Huge gap between clinical efficacy and community effectiveness in the treatment of chronic hepatitis C: A nationwide survey in Taiwan. Medicine, 94(13), e690. https:\/\/doi.org\/10.1097\/MD.0000000000000690","DOI":"10.1097\/MD.0000000000000690"}],"container-title":["Belitung Nursing Journal"],"original-title":[],"link":[{"URL":"https:\/\/www.belitungraya.org\/BRP\/index.php\/bnj\/article\/download\/4472\/1338","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.belitungraya.org\/BRP\/index.php\/bnj\/article\/download\/4472\/1358","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.belitungraya.org\/BRP\/index.php\/bnj\/article\/download\/4472\/1338","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T03:33:22Z","timestamp":1777347202000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.belitungraya.org\/BRP\/index.php\/bnj\/article\/view\/4472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":28,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,4,28]]}},"URL":"https:\/\/doi.org\/10.33546\/bnj.4472","relation":{},"ISSN":["2477-4073"],"issn-type":[{"value":"2477-4073","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"2025-11-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-10","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}